eCite Digital Repository

Morphine dosing strategy plays a key role in the generation and duration of the produced antinociceptive tolerance

Citation

Paul, AK and Gueven, N and Dietis, N, Morphine dosing strategy plays a key role in the generation and duration of the produced antinociceptive tolerance, Neuropharmacology, 121 pp. 158-166. ISSN 0028-3908 (2017) [Refereed Article]


Preview
PDF (Final version (pdf) with restricted access)
Pending copyright assessment - Request a copy
1Mb
  

Abstract

Antinociceptive tolerance after repetitive administration of morphine severely limits its clinical use. Despite increased mechanistic understanding of morphine tolerance, little is known about the influence of dosing regimens in its development. We hypothesized that the starting dose of morphine, dosing frequency and dose increments, influence antinociception and the manifestation of antinociceptive tolerance in rats. Male rats were randomly divided into four groups with different intermittent startingdoses of daily morphine (b.i.d.) followed by different increments of single-dose morphine upon development of antinociceptive tolerance, for 2e3 weeks: 2.5 (b.i.d.)/5 / 10/15 mg/kg/day, 5 (b.i.d.)/ 10 mg/kg/day, 5 (b.i.d.)/15 mg/kg/day, 10 (b.i.d.)/20 mg/kg/day. Antinociception was assessed daily pre-treatment and at several time-points over 2 h post-administration, using tail-flick and hot-plate assays. Tolerance was defined as significant antinociceptive desensitization and was presented as significant reduction of the maximum and total antinociceptive efficacy upon morphine administration. Rats commenced on 2.5 mg/kg/day (b.i.d.) morphine developed tolerance faster than those started on 5 or 10 mg/kg/day (b.i.d.). Comparatively, higher starting and maintenance doses of morphine produced prolonged antinociception and delayed tolerance. Whereas, lower starting and maintenance doses of morphine produced less total antinociception during the course of treatment and did not delay the onset of tolerance, but require smaller dose-increments to reach antinociception after development of antinociceptive tolerance. These results suggest that morphine starting dose, dosing frequency, increments and timing determine the manifestation of antinociceptive tolerance and extent of antinociception. In addition, our results also highlight the need for generally standardized and validated assay protocols and procedures to compare different studies, as a prerequisite to translate pre-clinical results into the clinic.

Item Details

Item Type:Refereed Article
Keywords:Morphine; Dosing regimen; Antinociceptive tolerance; Antinociception
Research Division:Medical and Health Sciences
Research Group:Pharmacology and Pharmaceutical Sciences
Research Field:Basic Pharmacology
Objective Division:Manufacturing
Objective Group:Human Pharmaceutical Products
Objective Field:Human Pharmaceutical Products not elsewhere classified
Author:Paul, AK (Mr Alok Paul)
Author:Gueven, N (Associate Professor Nuri Gueven)
Author:Dietis, N (Dr Nikolas Dietis)
ID Code:116713
Year Published:2017
Deposited By:Pharmacy
Deposited On:2017-05-17
Last Modified:2017-05-18
Downloads:0

Repository Staff Only: item control page